News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Clinical Development of Solasia’s First Drug Initiated in Japan – Clinical Trials Also Planned for China


3/9/2009 11:32:38 AM

TOKYO--(BUSINESS WIRE)--Solasia Pharma K.K. (http://www.solasia.co.jp/en/index.html), a developer of Western oncology pharmaceuticals in-licensed for commercialization in Asian markets, announced today initiation of a Phase 1 study of SP-01 (long-acting transdermal granisetron patch; brand name: Sancuso®) in Japanese volunteers. This represents the first study implemented by Solasia.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES